Gilbert Cisneros
Tickers in This Filing
Stock Price at Trade vs. Today
Real market data showing how each stock moved since the congress member traded it.
Suspicious Timing Detected
5 flagsGilbert Cisneros bought $1,001 - $15,000 in $LMT on 2025-08-05, 56 days before the Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 (HR3838) was enacted, which significantly impacts defense contractors.
Gilbert Cisneros bought $1,001 - $15,000 in $ELV on 2025-08-05, 44 days before the Protecting Free Vaccines Act (HR5448) was introduced, which would mandate no-cost coverage for ACIP-recommended vaccines.
Gilbert Cisneros bought $1,001 - $15,000 in $MRK on 2025-08-05, 30 days before the PrEP and PEP are Prevention Act (HR5127) was introduced, which mandates no-cost coverage for HIV prevention drugs.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $LB | LandBridge Company LLC Class A Shares Representing Limited Liability Company Interests (LB) [ST] | $50K-$100K | — | — | — | Aug 6, 2025 |
| BUY | $STRC | Strategy Inc - Variable Rate Series A Perpetual Stretch Preferred Stock (STRC) [ST] | $15K-$50K | — | — | — | Aug 6, 2025 |
| BUY | $APA | APA Corporation - Common Stock (APA) [ST] | $1K-$15K | — | — | — | Aug 5, 2025 |
| BUY | $APG | APi Group Corporation Common Stock (APG) [ST] | $1K-$15K | — | — | — | Aug 26, 2025 |
| BUY | $AVNT | Avient Corporation Common Stock (AVNT) [ST] | $1K-$15K | — | — | — | Sep 2, 2025 |
| BUY | $BBIO | BridgeBio Pharma, Inc. - Common Stock (BBIO) [ST] | $1K-$15K | — | — | — | Aug 8, 2025 |
| BUY | $CHRW | C.H. Robinson Worldwide, Inc. - Common Stock (CHRW) [ST] | $1K-$15K | — | — | — | Aug 5, 2025 |
| BUY | $CNC | Centene Corporation Common Stock (CNC) [ST] | $1K-$15K | — | $41.09 | — | Aug 5, 2025 |
| BUY | $CVLT | Commvault Systems, Inc. - Common Stock (CVLT) [ST] | $1K-$15K | — | $90.15 | — | Aug 15, 2025 |
| BUY | $CAG | ConAgra Brands, Inc. Common Stock (CAG) [ST] | $1K-$15K | — | — | — | Aug 5, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
PrEP and PEP are Prevention Act
The PrEP and PEP are Prevention Act mandates no-cost coverage for HIV prevention drugs and related services, directly increasing demand for these medications and associated diagnostic tests. This legislation creates a guaranteed market expansion for pharmaceutical companies producing PrEP/PEP drugs and diagnostic providers, while increasing costs for health insurers.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
HR3838, the Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026, significantly increases authorized appropriations for military activities and defense programs for FY2026. This legislation streamlines procurement processes, directly benefiting major defense primes and technology providers to the Department of Defense by increasing potential contract volume and accelerating acquisition timelines. The bill has passed the House and is currently in the Senate, indicating strong legislative momentum.
PIPES Act of 2025
The PIPES Act of 2025 (HR5301) has advanced out of committee, signaling strong legislative support for pipeline infrastructure investment and regulatory stability. This bill authorizes federal funding for pipeline safety and workforce development, directly benefiting pipeline operators, energy infrastructure manufacturers, and construction firms. While the bill authorizes appropriations, actual funding will depend on subsequent legislation.
To authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to products of certain countries.
HR5917 authorizes the President to grant normal trade relations (NTR) status to most countries, excluding Belarus, Cuba, and North Korea, by waiving the Jackson-Vanik amendment. This action reduces tariffs and trade barriers for goods from these countries, directly benefiting U.S. importers and consumers through lower costs. Companies relying on global supply chains will see improved margins and increased access to goods.
Protecting Free Vaccines Act of 2025
The 'Protecting Free Vaccines Act of 2025' (S.2857) is in the early stages, having been referred to committee. This bill aims to codify existing mandates for ACIP-recommended immunization coverage, ensuring stable revenue for vaccine manufacturers and health insurers by preventing future disruptions to current vaccine coverage. It does not introduce new market drivers or significant changes to demand.
Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025
The Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 (HR5199) has been introduced in the House and referred to two committees. This bill aims to expand independent practice authority for PAs and NPs in rural facilities, which could reduce operational costs for healthcare providers and insurers starting January 1, 2027, if enacted. The bill does not specify any direct funding amounts.
BRISTOW LLC: $32.0M Department of the Interior Contract
This $32.0 million contract to Bristow LLC for helicopter flight services supports offshore energy operations, providing a steady revenue stream for the company. While not transformative, it reinforces Bristow's position in a critical support sector.
Protecting Free Vaccines Act
The 'Protecting Free Vaccines Act' (HR5448) is an early-stage bill that, if enacted, would mandate no-cost coverage for ACIP-recommended vaccines by Medicare, Medicaid, CHIP, and private insurers until January 1, 2030. This would directly increase demand for vaccine manufacturers and shift cost burdens to health insurers and government programs. Vaccine manufacturers are positioned for sustained revenue growth, while health insurers face increased costs.
Stop Chinese Fentanyl Act of 2025
The 'Stop Chinese Fentanyl Act of 2025' (HR747) is an early-stage bill that expands sanctions on Chinese entities involved in opioid and precursor production. This legislation directly impacts U.S. companies with chemical supply chain ties to China, increasing operational costs and creating potential supply chain disruptions for chemical manufacturers and logistics firms. The bill has seen recent committee activity, indicating some legislative momentum.
Medicare Advantage Prompt Pay Act
The Medicare Advantage Prompt Pay Act (HR5454) is in early legislative stages, mandating stricter payment timelines for Medicare Advantage organizations. This bill is expected to increase administrative costs and reduce cash flow flexibility for these plans, while benefiting healthcare providers through faster payments. Despite this, major Medicare Advantage providers have seen recent stock price increases, with $UNH up 12.38% in 7 days and $HUM up 10.8% in 7 days.
Live Charts
Other Filings by Gilbert Cisneros
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.